BioPharma Credit PLC (LON:BPCR)

London flag London · Delayed Price · Currency is GBP · Price in USD
0.9320
-0.0040 (-0.43%)
At close: Mar 4, 2026
Market Cap794.07M -0.1%
Revenue (ttm)112.89M +13.4%
Net Income89.87M +12.6%
EPS0.08 +22.2%
Shares Out1.13B
PE Ratio8.93
Forward PEn/a
Dividend0.07 (10.30%)
Ex-Dividend DateFeb 19, 2026
Volume2,248,240
Average Volume1,666,660
Open0.9300
Previous Close0.9360
Day's Range0.9220 - 0.9360
52-Week Range0.8000 - 0.9798
Beta0.17
RSI47.86
Earnings DateMar 24, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. The company debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in Leeds, the United Kingdom. [Read more]

Sector Financials
Founded 2016
Country United Kingdom
Stock Exchange London Stock Exchange
Ticker Symbol BPCR
Full Company Profile

Financial Performance

In 2024, BioPharma Credit's revenue was $150.03 million, an increase of 10.53% compared to the previous year's $135.74 million. Earnings were $122.18 million, an increase of 12.66%.

Financial numbers in USD Financial Statements